Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Antonio Passaro
Apr 15, 2024, 13:28 |
Insight
Antonio Passaro: Release of our editorial, co-authored with Peters Solange, focusing on the groundbreaking ALINA study
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared on LinkedIn: ''I am thrilled…
Apr 15, 2024, 01:09 |
Blog
Antonio Passaro: Our editorial on the groundbreaking ALINA trial
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared on X/Twitter: "Just published in…
Apr 8, 2024, 16:54 |
Blog
Antonio Passaro: The phase 3 KRYSTAL-12 trial represents a significant advancement in our understanding and treatment of KRAS-mutated NSCLC
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared a post on LinkedIn: "Why…
Apr 6, 2024, 07:14 |
Drugs
Antonio Passaro: Why is this press release of Bristol Myers Squibb so crucial for our community?
Antonio Passaro, Medical Director at the Institute of European Oncology (IEO), shared a post on…
Apr 2, 2024, 12:50 |
Blog
Antonio Passaro: Key milestones in cancer biomarker research and future avenues for enhancing the management of patients with solid tumors
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared a post on LinkedIn:…
Jan 27, 2024, 22:56 |
Blog
Antonio Passaro: This scientific journey has not only been immensely interesting but exceptionally fruitful
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared on LinkedIn: "Delighted to…
Oct 29, 2023, 03:16 |
Drugs
Antonio Passaro: I was honored to present in Presidential, the primary results of the global randomized phase 3 study MARIPOSA-2
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared on LinkedIn: "ESMO23 is…
Jun 19, 2023, 18:11 |
Drugs
Antibody-drug conjugates (ADCs) have emerged as one of the fastest-growing oncology therapeutics - Antonio Passaro
I am delighted to share the our recent publication in JCO titled "Antibody-Drug Conjugates in…
Jun 8, 2023, 19:13 |
Stories
Last year's congress left an indelible impression on me - Antonio Passaro
I am thrilled to express my appreciation for the opportunity to participate in the recent…
Jul 19, 2024, 22:55 |
Blog
What after Osimertinib failure?
Abhishek Pathak, Professor at the Indian Army, shared a post on X: "What after Osimertinib…
1
2
3
All:
24
Posts:
11 - 20
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube